Credit Suisse’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $1.87M | Buy |
43,164
+1,152
| +3% | +$49.9K | ﹤0.01% | 1896 |
|
2023
Q4 | $1.93M | Sell |
42,012
-1,306
| -3% | -$60K | ﹤0.01% | 1902 |
|
2023
Q3 | $993K | Sell |
43,318
-25,683
| -37% | -$589K | ﹤0.01% | 2302 |
|
2023
Q2 | $1.14M | Buy |
69,001
+13,710
| +25% | +$226K | ﹤0.01% | 2282 |
|
2023
Q1 | $986K | Buy |
55,291
+7,879
| +17% | +$141K | ﹤0.01% | 2323 |
|
2022
Q4 | $1.38M | Buy |
47,412
+11,928
| +34% | +$347K | ﹤0.01% | 2103 |
|
2022
Q3 | $869K | Buy |
35,484
+10,962
| +45% | +$268K | ﹤0.01% | 2413 |
|
2022
Q2 | $102K | Sell |
24,522
-2,749
| -10% | -$11.4K | ﹤0.01% | 3507 |
|
2022
Q1 | $314K | Sell |
27,271
-1,146
| -4% | -$13.2K | ﹤0.01% | 3187 |
|
2021
Q4 | $283K | Buy |
28,417
+2,837
| +11% | +$28.3K | ﹤0.01% | 3317 |
|
2021
Q3 | $335K | Buy |
25,580
+1,778
| +7% | +$23.3K | ﹤0.01% | 3214 |
|
2021
Q2 | $467K | Sell |
23,802
-1,654
| -6% | -$32.5K | ﹤0.01% | 3064 |
|
2021
Q1 | $541K | Sell |
25,456
-18,820
| -43% | -$400K | ﹤0.01% | 2905 |
|
2020
Q4 | $1.32M | Buy |
44,276
+27,216
| +160% | +$810K | ﹤0.01% | 2391 |
|
2020
Q3 | $369K | Sell |
17,060
-19,993
| -54% | -$432K | ﹤0.01% | 2812 |
|
2020
Q2 | $826K | Buy |
37,053
+22,915
| +162% | +$511K | ﹤0.01% | 2407 |
|
2020
Q1 | $215K | Sell |
14,138
-1,014
| -7% | -$15.4K | ﹤0.01% | 3005 |
|
2019
Q4 | $347K | Buy |
15,152
+3,846
| +34% | +$88.1K | ﹤0.01% | 3101 |
|
2019
Q3 | $244K | Sell |
11,306
-2,877
| -20% | -$62.1K | ﹤0.01% | 3125 |
|
2019
Q2 | $311K | Buy |
14,183
+4,648
| +49% | +$102K | ﹤0.01% | 3027 |
|
2019
Q1 | $261K | Buy |
9,535
+855
| +10% | +$23.4K | ﹤0.01% | 3074 |
|
2018
Q4 | $233K | Sell |
8,680
-7,270
| -46% | -$195K | ﹤0.01% | 3086 |
|
2018
Q3 | $466K | Buy |
15,950
+7,154
| +81% | +$209K | ﹤0.01% | 2883 |
|
2018
Q2 | $275K | Buy |
+8,796
| New | +$275K | ﹤0.01% | 3195 |
|